With 2016 now in the books, investors can now look ahead for 2017. Market shifts are already underway, and the year’s economic waters remain uncharted as we look to the potential effects of the new administration. Most market analysts agree that 2017 will be another positive year for growth, but, as is typically the case, new developments often create new pitfalls and potential volatility....More>>>
Baird’sBen Kallo andTyler Frank explain why they’d be buyers of Tesla Motors (TSLA) “at current levels”:
We are upgrading Teslato Outperform and raising our price target to $300. Webelieve investor skepticism has significantly increased since we downgraded TeslaonOct. 6, and although we were concerned about the rate of Model X deliveries,....More>>>
Investors might be giving up on the so-called reflation trade too soon, according to Deutsche Bank.Top 10 Heal Care Stocks To Buy Right Now: Oshkosh Corporation(OSK)
Trivago stock is up nearly 10% to $12.07 following its IPO today (Friday). When the stock finally opened shortly before 11 a.m., shares were up a muted $0.20 at $11.20.
Trivago NV (Nasdaq: TRVG) is a German hotel-search company. It priced its initial public offering of 26.1 million American depositary shares (ADSs) at $11 apiece. That was below its projected number of shares and price....More>>>
On Wednesday, our Under the Radar Moversnewsletter suggestedsmall cap oncology stock Champions Oncology (NASDAQ: CSBR) as a buy for our short-term portfolio:
Normally we’d like for a new “turnaround” trade to be decisively above the 200-day moving average line (green) before pulling the trigger. We’re going to go ahead and step into Champions Oncology anyway, though,....More>>>